Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Envoy Medical Inc (COCH)

Envoy Medical Inc (COCH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 43,729
  • Shares Outstanding, K 20,245
  • Annual Sales, $ 320 K
  • Annual Income, $ -29,910 K
  • EBIT $ -27 M
  • EBITDA $ -27 M
  • 60-Month Beta 2.23
  • Price/Sales 134.54
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.33
  • Number of Estimates 3
  • High Estimate -0.24
  • Low Estimate -0.39
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.03%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.85 +18.92%
on 11/07/24
2.32 -5.17%
on 12/02/24
+0.24 (+12.24%)
since 11/06/24
3-Month
1.72 +27.91%
on 11/06/24
3.99 -44.86%
on 09/23/24
-0.90 (-29.03%)
since 09/06/24
52-Week
1.08 +103.70%
on 01/30/24
11.46 -80.80%
on 03/07/24
+0.24 (+12.24%)
since 12/06/23

Most Recent Stories

More News
Envoy Medical Reports Q3 2024 Financial Results and Progress on Fully Implanted Hearing Devices

Envoy Medical reports Q3 2024 results, highlighting FDA approval for Acclaim CI trial and reimbursement progress for Esteem device.Quiver AI SummaryEnvoy Medical, Inc. reported its third-quarter financial...

COCH : 2.20 (+1.85%)
Envoy Medical Reports Third Quarter 2024 Results and Other Exciting Events

COCH : 2.20 (+1.85%)
Envoy Medical’s Fully Implanted Acclaim® Cochlear Implant Highlighted in Peer-Reviewed Publication

COCH : 2.20 (+1.85%)
Building Permits, Vehicle Sales Due Next Week

Monday U.S. Featured Earnings Monday.Com Ltd (NASDAQ: MNDY) (Q3) EPS of four cents, compared ...

BABA : 85.93 (+2.12%)
HAFN : 5.22 (-2.81%)
AMAT : 173.02 (+0.58%)
CSCO : 59.89 (-0.22%)
NVA.TO : 13.37 (-0.89%)
NU : 12.03 (+0.59%)
BN : 59.81 (-0.37%)
COCH : 2.20 (+1.85%)
DIS : 116.73 (+0.20%)
SHOP : 118.37 (+3.75%)
ARMK : 41.61 (+0.02%)
ZETA : 26.18 (+1.51%)
Envoy Medical Receives Another European Patent for its Modular Cochlear Implant System

COCH : 2.20 (+1.85%)
Envoy Medical Receives FDA Approval To Initiate Pivotal Clinical Study for Breakthrough Hearing Device

COCH : 2.20 (+1.85%)
Key Advocates Urge CMS to Clarify that Fully Implanted Active Middle Ear Hearing Devices are Prosthetic Devices for Purposes of Medicare Coverage

COCH : 2.20 (+1.85%)
Envoy Medical to Present at the LD Micro Main Event XVII

COCH : 2.20 (+1.85%)
American Medical Association Approves Groundbreaking New CPT Codes for Totally Implantable Active Middle Ear Hearing Implants Opening New Opportunities for Envoy Medical’s Esteem® Device

COCH : 2.20 (+1.85%)
Envoy Medical, Inc. to Present at The Microcap Conference

White Bear Lake, Minnesota--(Newsfile Corp. - January 30, 2024) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing health company focused on fully implanted hearing systems,...

COCH : 2.20 (+1.85%)

Business Summary

Envoy Medical Inc. is a medical technology company focused on fully implanted hearing devices. The company's primary device is the fully implanted Acclaim(R) cochlear implant. Envoy Medical Inc., formerly known as Anzu Special Acquisition Corp I, is headquartered in White Bear Lake, Minnesota.

See More

Key Turning Points

3rd Resistance Point 2.50
2nd Resistance Point 2.39
1st Resistance Point 2.29
Last Price 2.20
1st Support Level 2.08
2nd Support Level 1.97
3rd Support Level 1.87

See More

52-Week High 11.46
Fibonacci 61.8% 7.49
Fibonacci 50% 6.27
Fibonacci 38.2% 5.05
Last Price 2.20
52-Week Low 1.08

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar